Key result
Poor medication adherence to dual antiplatelet therapy after percutaneous coronary intervention for acute myocardial infarction is common and strongly predicts adverse cardiovascular outcomes.
Population
Patients after percutaneous coronary intervention due to acute myocardial infarction
Design
Review
Authors
Loading...
Adherence strategies warrant emphasis post-AMI PCI; supports consensus while extending predictor data.
Medication non-adherence remains a major challenge in secondary prevention after AMI treated with PCI, necessitating improved patient education and interprofessional collaboration.
Świeczkowski et al. (2013) conducted a review in Acute myocardial infarction treated with percutaneous coronary intervention. Medication adherence (antiplatelet therapy) vs. Non-adherence was evaluated. Poor medication adherence to dual antiplatelet therapy after percutaneous coronary intervention for acute myocardial infarction is common and strongly predicts adverse cardiovascular outcomes.